SCARAMUZZINO, LUANA
 Distribuzione geografica
Continente #
NA - Nord America 248
EU - Europa 148
AS - Asia 119
SA - Sud America 17
AF - Africa 3
OC - Oceania 1
Totale 536
Nazione #
US - Stati Uniti d'America 243
SG - Singapore 99
IT - Italia 68
DE - Germania 32
BR - Brasile 16
GB - Regno Unito 12
FI - Finlandia 9
FR - Francia 6
SE - Svezia 6
CN - Cina 4
CZ - Repubblica Ceca 4
IN - India 4
ES - Italia 3
HK - Hong Kong 3
JP - Giappone 3
NL - Olanda 3
BD - Bangladesh 2
CA - Canada 2
MX - Messico 2
UA - Ucraina 2
VN - Vietnam 2
ZA - Sudafrica 2
AT - Austria 1
AU - Australia 1
BB - Barbados 1
CL - Cile 1
GR - Grecia 1
MA - Marocco 1
MY - Malesia 1
PL - Polonia 1
TR - Turchia 1
Totale 536
Città #
Singapore 75
Chandler 37
Munich 28
Santa Clara 17
San Nicola Manfredi 15
Lawrence 13
Princeton 13
Boardman 9
Milan 9
Chicago 8
London 8
Ashburn 7
Naples 7
Turku 7
New York 6
Brooklyn 5
Port Richey 5
Olomouc 4
Aversa 3
Council Bluffs 3
Dallas 3
Hong Kong 3
Squillace 3
Tokyo 3
Afragola 2
Bari 2
Borås 2
Caserta 2
Catanzaro 2
Chennai 2
Da Nang 2
Denver 2
Des Moines 2
Helsinki 2
Los Angeles 2
Mexico City 2
Paris 2
Rome 2
San Vito dei Normanni 2
Settingiano 2
Stockholm 2
São Paulo 2
The Dalles 2
Toronto 2
Turin 2
Alexandria 1
Atibaia 1
Barbacena 1
Baton Rouge 1
Belo Horizonte 1
Bismarck 1
Boston 1
Bridgetown 1
Böblingen 1
Cachoeirinha 1
Cape Town 1
Charlotte 1
Cleveland 1
Cortale 1
Decatur 1
Delhi 1
Eden Prairie 1
Germantown 1
Guangzhou 1
Honolulu 1
Hortolândia 1
Iguaba Grande 1
Istanbul 1
Itajaí 1
Johannesburg 1
Juneau 1
Lakewood 1
Maceió 1
Madrid 1
Manchester 1
Mandirituba 1
Marseille 1
Norwalk 1
Noākhāli 1
Nuremberg 1
Oujda 1
Palermo 1
Pasir Mas 1
Pune 1
Redmond 1
Redwood City 1
Richmond 1
Rio Grande 1
Rogliano 1
San Jose 1
Santiago 1
Schaumburg 1
Seattle 1
Secaucus 1
Senador Camará 1
Shanghai 1
Stockton 1
Sydney 1
São Gabriel 1
Teotônio Vilela 1
Totale 388
Nome #
A disposable passive microfluidic device for cell culturing 53
Induced pluripotent stem cells versus embryonic stem cells 36
Uncovering the metabolic and stress responses of human embryonic stem cells to FTH1 gene silencing 36
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 35
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease 34
Modeling cardiac disease mechanisms using induced pluripotent stem cell-derived cardiomyocytes: Progress, promises and challenges 31
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 29
Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs 27
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 27
Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene 27
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 27
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 26
Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study 23
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 22
Serum Oligomeric α-Synuclein and p-tau181 in Progressive Supranuclear Palsy and Parkinson’s Disease 21
Unraveling the impact of ZZZ3 on the mTOR/ribosome pathway in human embryonic stem cells homeostasis 20
Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine 20
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 18
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 16
Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study 13
Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study 12
Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy 11
Totale 564
Categoria #
all - tutte 7.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 1 0 0 2 1 0 0 4 0 1
2021/202231 1 0 0 2 0 0 1 8 1 7 10 1
2022/2023124 27 15 13 0 12 3 0 9 20 8 9 8
2023/202470 16 7 2 5 3 11 1 0 0 0 10 15
2024/2025257 31 3 2 2 19 31 22 6 11 0 35 95
2025/202673 52 21 0 0 0 0 0 0 0 0 0 0
Totale 564